Drug Profile
Anaritide
Alternative Names: Auriculin; hANP (102-126); WY 47663Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Scios
- Developer Genentech; Scios
- Class Antihypertensives; Anxiolytics; Heart failure therapies; Hormones; Natriuretic peptides
- Mechanism of Action Atrial peptide agonists; Diuretics
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Heart failure; Hypertension; Renal failure
Most Recent Events
- 06 Nov 1997 Discontinued-Clinical for Heart failure in USA (IV)
- 06 Nov 1997 Discontinued-Clinical for Hypertension in European Union (IV)
- 06 Nov 1997 Discontinued-Clinical for Hypertension in USA (IV)